THG insider ownership: who sold, why, and what they still hold

What stands out

Four officers sold $9.9M with no disclosed plan: Richard Lavey ($4.4M), Bryan Salvatore ($3.0M) and Denise Lowsley ($1.3M), plus 1 more. The filings don't state a reason.Richard Lavey: largest such sale, Feb 5, 2026 · Bryan Salvatore: largest such sale, Jun 3, 2026 · Denise Lowsley: largest such sale, May 14, 2026

Tax withholding outweighed market sales: the company withheld $24.5M of officers' and directors' shares for taxes, against $16.2M sold on the open market. The largest was Jeffrey Farber ($12.5M withheld).Largest withholding, Jul 29, 2026

A share of stake is shown for 0 of the 10 officers and directors who sold. 19 are left out

Left out: John Roche, Jeffrey Farber, Richard Lavey, Joseph Ramrath, Bryan Salvatore, Cynthia Egan, Dennis Kerrigan, Kevin Bradicich, Kathy Lane, Theodore Bunting Jr., Paul Condrin, Willard Lee, Denise Lowsley, Elizabeth Ward, Francisco Aristeguieta, David Lovely, Patricia Norton-Gatto, William Donnell and Jane Carlin (share of stake is being verified).

Disclosed company stock is not an insider's whole wealth.

Who sold, and how much of their stake

Officers and directors, past 12 months. Their share of stake is being verified and is not shown yet; amounts and trading plans are below.

Richard Lavey

Executive Vice President

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$4.4MNo plan disclosed

Dennis Kerrigan

Executive Vice President

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$3.1M61% planned 39% no plan disclosed

Bryan Salvatore

Executive Vice President

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$3.0MNo plan disclosed

John Roche

President and CEO, Director

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$2.7MDisclosed plan

Denise Lowsley

Executive Vice President

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$1.3MNo plan disclosed

All 10 sellers

Selling by month

Officers and directors, Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planNo plan disclosedOne dollar scale for every month; the tallest bar is labeled

Recent activity

Past 30 days, Sep 17, 2026 to Oct 16, 2026

No officer or director trades were reported for the past 30 days. The most recent before that:

Aug 20, 2026Dennis Kerrigan sold 2.1K shares ($468K) under a disclosed trading plan. 2.1K shares came in from vesting or option exercises the same day, so the holding rose by 0 net.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
Dennis Kerrigan Executive Vice President	2,104	$222.41	n/a	n/a	Aug 20, 2026	Aug 21, 2026

Common questions

Is the Hanover Insurance Group, Inc. CEO selling stock?

Yes. John Roche sold 14K shares ($2.7M) in the past 12 months, all of it under a trading plan disclosed in the filings.

Why are Hanover Insurance Group, Inc. insiders selling?

Filings rarely give a reason, and we don't guess at one. What they show is how the sales were made: 28% of sales by value ran under 10b5-1 trading plans disclosed in the filings and 72% had no disclosed plan. A trading plan schedules sales in advance.

Are any Hanover Insurance Group, Inc. insiders buying?

No. Officers and directors reported no purchases in the past 12 months.

The evidence

Who sold10 officers and directors: amount, % of holdings, trading plan

Who sold	Amount	% of holdings	Trading plan
Richard Lavey Executive Vice President	$4.4M 24K shares	Not confirmed share of stake is being verified. Why	No plan disclosed
Dennis Kerrigan Executive Vice President	$3.1M 15K shares	Not confirmed share of stake is being verified. Why	61% under a disclosed plan 39% no plan disclosed
Bryan Salvatore Executive Vice President	$3.0M 16K shares	Not confirmed share of stake is being verified. Why	No plan disclosed
John Roche President and CEO, Director	$2.7M 14K shares	Not confirmed share of stake is being verified. Why	Disclosed plan
Denise Lowsley Executive Vice President	$1.3M 6.9K shares	Not confirmed share of stake is being verified. Why	No plan disclosed
Cynthia Egan Director	$641K 3.4K shares	Not confirmed share of stake is being verified. Why	No plan disclosed
Jane Carlin Director	$449K 2.2K shares	Not confirmed share of stake is being verified. Why	No plan disclosed
Theodore Bunting Jr. Director	$275K 1.2K shares	Not confirmed share of stake is being verified. Why	No plan disclosed
Francisco Aristeguieta Director	$195K 1K shares	Not confirmed share of stake is being verified. Why	No plan disclosed
Willard Lee Executive Vice President	$184K 1K shares	Not confirmed share of stake is being verified. Why	No plan disclosed

The full ownership picture0 of 19 officers and directors confirmed

Vested shares across all share classes, held directly and through trusts, LLCs and family members, as reported on SEC Forms 3, 4 and 5. Unvested awards and options are never counted as owned shares.

Insider

Held Oct 16, 2025

Sold

Held Oct 16, 2026

Still held

John Roche

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for John Roche are complete.

President and CEO, Director

n/a

−14K

n/a

Vesting, gifts, unvested awards and holding lines for John Roche

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for John Roche are complete; balances and unit counts will be added when the check is finished.

−590gifted (net of own trusts)

−52Kwithheld by the company for taxes

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
48,052	$104.11	Feb 27, 2028	$5.7M
41,437	$134.26	Feb 27, 2034	$3.7M
39,629	$161.82	Feb 25, 2035	$2.4M
45,025	$173.56	Feb 24, 2036	$2.2M

Estimate: options held × ($222.97 − strike price), using the most recent insider trade price on Form 4 (Aug 20, 2026), not a market close.

Jeffrey Farber

Executive Vice President

n/a

Vesting, gifts, unvested awards and holding lines for Jeffrey Farber

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Jeffrey Farber are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

−55Kwithheld by the company for taxes

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
15,332	$134.26	Feb 27, 2034	$1.4M
14,154	$161.82	Feb 25, 2035	$866K
14,436	$173.56	Feb 24, 2036	$713K

Estimate: options held × ($222.97 − strike price), using the most recent insider trade price on Form 4 (Aug 20, 2026), not a market close.

Richard Lavey

Executive Vice President

n/a

−24K

n/a

Vesting, gifts, unvested awards and holding lines for Richard Lavey

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Richard Lavey are complete; balances and unit counts will be added when the check is finished.

−1.4Kgifted (net of own trusts)

−3.2Kwithheld by the company for taxes

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
9,117	$134.26	Feb 27, 2034	$809K
9,377	$161.82	Feb 25, 2035	$573K
9,968	$173.56	Feb 24, 2036	$493K

Estimate: options held × ($222.97 − strike price), using the most recent insider trade price on Form 4 (Aug 20, 2026), not a market close.

Joseph Ramrath

Director

n/a

Vesting, gifts, unvested awards and holding lines for Joseph Ramrath

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Joseph Ramrath are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Bryan Salvatore

Executive Vice President

n/a

−16K

n/a

Vesting, gifts, unvested awards and holding lines for Bryan Salvatore

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Bryan Salvatore are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

−3Kwithheld by the company for taxes

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
8,288	$134.26	Feb 27, 2034	$735K
8,139	$161.82	Feb 25, 2035	$498K
8,937	$173.56	Feb 24, 2036	$442K

Estimate: options held × ($222.97 − strike price), using the most recent insider trade price on Form 4 (Aug 20, 2026), not a market close.

Cynthia Egan

Director

n/a

−3.4K

n/a

Vesting, gifts, unvested awards and holding lines for Cynthia Egan

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Cynthia Egan are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Dennis Kerrigan

Executive Vice President

n/a

−15K

n/a

Vesting, gifts, unvested awards and holding lines for Dennis Kerrigan

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Dennis Kerrigan are complete; balances and unit counts will be added when the check is finished.

−175gifted (net of own trusts)

−1.9Kwithheld by the company for taxes

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
5,387	$134.26	Feb 27, 2034	$478K
4,954	$161.82	Feb 25, 2035	$303K
5,328	$173.56	Feb 24, 2036	$263K

Estimate: options held × ($222.97 − strike price), using the most recent insider trade price on Form 4 (Aug 20, 2026), not a market close.

Kevin Bradicich

Director

n/a

Vesting, gifts, unvested awards and holding lines for Kevin Bradicich

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Kevin Bradicich are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Kathy Lane

Director

n/a

Vesting, gifts, unvested awards and holding lines for Kathy Lane

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Kathy Lane are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Theodore Bunting Jr.

Director

n/a

−1.2K

n/a

Vesting, gifts, unvested awards and holding lines for Theodore Bunting Jr.

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Theodore Bunting Jr. are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Paul Condrin

Director

n/a

Vesting, gifts, unvested awards and holding lines for Paul Condrin

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Paul Condrin are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Willard Lee

Executive Vice President

n/a

−1K

n/a

Vesting, gifts, unvested awards and holding lines for Willard Lee

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Willard Lee are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

−1.2Kwithheld by the company for taxes

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
3,523	$134.26	Feb 27, 2034	$313K
3,539	$161.82	Feb 25, 2035	$216K
3,781	$173.56	Feb 24, 2036	$187K

Estimate: options held × ($222.97 − strike price), using the most recent insider trade price on Form 4 (Aug 20, 2026), not a market close.

Denise Lowsley

Executive Vice President

n/a

−6.9K

n/a

Vesting, gifts, unvested awards and holding lines for Denise Lowsley

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Denise Lowsley are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

−1.2Kwithheld by the company for taxes

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
3,523	$134.26	Feb 27, 2034	$313K
3,185	$161.82	Feb 25, 2035	$195K
3,094	$173.56	Feb 24, 2036	$153K

Estimate: options held × ($222.97 − strike price), using the most recent insider trade price on Form 4 (Aug 20, 2026), not a market close.

Elizabeth Ward

Director

n/a

Vesting, gifts, unvested awards and holding lines for Elizabeth Ward

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Elizabeth Ward are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Francisco Aristeguieta

Director

n/a

−1K

n/a

Vesting, gifts, unvested awards and holding lines for Francisco Aristeguieta

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Francisco Aristeguieta are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

David Lovely

Executive Vice President

n/a

Vesting, gifts, unvested awards and holding lines for David Lovely

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for David Lovely are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

−1.1Kwithheld by the company for taxes

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
3,315	$134.26	Feb 27, 2034	$294K
3,539	$161.82	Feb 25, 2035	$216K
3,781	$173.56	Feb 24, 2036	$187K

Estimate: options held × ($222.97 − strike price), using the most recent insider trade price on Form 4 (Aug 20, 2026), not a market close.

Patricia Norton-Gatto

SVP & Princpl. Accntg. Officer

n/a

Vesting, gifts, unvested awards and holding lines for Patricia Norton-Gatto

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Patricia Norton-Gatto are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
920	$161.82	Feb 25, 2035	$56K
963	$173.56	Feb 24, 2036	$48K

Estimate: options held × ($222.97 − strike price), using the most recent insider trade price on Form 4 (Aug 20, 2026), not a market close.

William Donnell

Director

n/a

Vesting, gifts, unvested awards and holding lines for William Donnell

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for William Donnell are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Jane Carlin

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. See the filing Sales and other transactions for Jane Carlin are complete.

Director

n/a

−2.2K

n/a

Vesting, gifts, unvested awards and holding lines for Jane Carlin

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Jane Carlin are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Holdings and share of stake for Hanover Insurance Group, Inc. are being verified, so no balances, unit counts or percentages are shown. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings.

What explains the selling$16.2M of sales by plan status, purpose, seller and month

Officer and director open-market sales: $16.2M across 84,996 shares. Plan status and stated purpose are separate questions, and a sale can have both.

By plan status

Disclosed plan · $4.6M · 28%

72%

The lighter segment is sales with no plan disclosed in the filing ($11.7M), including tax-related sales outside a plan.

No plan disclosed · $11.7M

Sales with no 10b5-1 plan and no tax reference in the filing. $4.4M of it is Richard Lavey. No plan disclosed is a statement about the filing, not about why the sale happened. Largest such sale: Bryan Salvatore, Jun 3, 2026

Taxes

$2.7M of sales (16.4%) cite tax obligations in their footnotes, $2.7M of them also under a plan. Separately, 118,944 shares ($24.5M) were withheld by the company for taxes, which isn't a market sale. Example: John Roche, May 20, 2026

Charitable gifts · 2.2K shares

Gifts the filings describe as charitable. Gifts are not sales and are not included in the sale totals.

Seller	Shares sold	Proceeds	Under a disclosed plan	Share of total	Sales dates
Richard Lavey Executive Vice President	24K	$4.4M	0%	27%	Feb 5, 2026 to Feb 5, 2026
Dennis Kerrigan Executive Vice President	15K	$3.1M	61%	19%	May 20, 2026 to Aug 20, 2026
Bryan Salvatore Executive Vice President	16K	$3.0M	0%	19%	Jun 3, 2026 to Jun 3, 2026
John Roche President and CEO, Director	14K	$2.7M	100%	16%	May 18, 2026 to May 20, 2026
Denise Lowsley Executive Vice President	6.9K	$1.3M	0%	8%	Nov 12, 2025 to May 14, 2026
Cynthia Egan Director	3.4K	$641K	0%	4%	May 1, 2026 to May 1, 2026
Jane Carlin Director	2.2K	$449K	0%	3%	Feb 27, 2026 to Aug 3, 2026
Theodore Bunting Jr. Director	1.2K	$275K	0%	2%	Aug 5, 2026 to Aug 6, 2026
Francisco Aristeguieta Director	1K	$195K	0%	1%	May 21, 2026 to May 21, 2026
Willard Lee Executive Vice President	1K	$184K	0%	1%	May 4, 2026 to May 4, 2026

Sales by month

Month	Sale proceeds	Disclosed plan	To cover taxes	No plan disclosed
Oct 2025	$0	$0	$0	$0
Nov 2025	$294K	$0	$0	$294K
Dec 2025	$0	$0	$0	$0
Jan 2026	$0	$0	$0	$0
Feb 2026	$4.6M	$0	$0	$4.6M
Mar 2026	$0	$0	$0	$0
Apr 2026	$0	$0	$0	$0
May 2026	$5.9M	$2.7M	$0	$3.2M
Jun 2026	$3.0M	$0	$0	$3.0M
Jul 2026	$0	$0	$0	$0
Aug 2026	$2.4M	$1.9M	$0	$506K
Sep 2026	$0	$0	$0	$0
Oct 2026	$0	$0	$0	$0

Is this normal? Selling year by year5 earlier years to compare with

More than usual: about 1.9x the 5-year average. 10 insiders sold; the average is 6 a year.

12 months ending	Shares sold	Insiders who sold	Proceeds
Oct 16, 2026 Latest 12 months	85K	10	$16.2M
Oct 16, 2025 1 year earlier	88K	6	$14.7M
Oct 16, 2024 2 years earlier	30K	6	$4.3M
Oct 17, 2023 3 years earlier	4.8K	3	$642K
Oct 17, 2022 4 years earlier	45K	5	$6.5M
Oct 17, 2021 5 years earlier	60K	8	$8.2M

Open-market sales (Form 4 code S) by people who were officers or directors, in split-adjusted shares. Earlier years include people who have since left. A sale that an outside holder also reports (a family trust, a fund) is counted with outside holders in every year. Shares, not dollars, are compared, so a change in the stock price doesn't look like a change in selling. Years the filings don't fully cover are shown but left out of the average.

Known gaps and uncertainty19 officers and directors not confirmed

Holdings and share of stake are being verified. Balances, unit counts and every share-of-stake figure for Hanover Insurance Group, Inc. are held back until that check is finished. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings and are complete.

External context: we only cite outside events when a documented connection exists. None is shown for this period.

Sources and methodology1,572 filings on record, 102 filed in the 12-month period, and how we read them

All 1,572 Forms 3, 4 and 5 on record for Hanover Insurance Group, Inc. (SEC CIK 944695), filed from May 15, 2003 to Sep 28, 2026; 102 of them were filed in the 12 months this page covers, retrieved from SEC EDGAR on Oct 16, 2026. Prices are the ones reported in each filing, often weighted averages.

Holdings. Each holding line (a share class plus an owner, such as a trust or LLC) carries its last reported balance forward. Entities first reported during the period start at zero, so transfers between an insider's own trusts don't count as selling. Lines not reported for three years or more are listed separately and left out of totals.

Sales. A sale counts as under a 10b5-1 plan if its footnote cites one or the filing's Rule 10b5-1 box is checked, and as tax-related if its footnote cites tax obligations or sell-to-cover. Shares withheld by the company for taxes are listed separately. Sales with neither attribute are labeled "no plan disclosed".

Full methodology

Former or inactive filers (57)No filing in 18 months; last reported balances, not in any total

Name	Last filed	Last reported balance
Warren Barnes	Feb 26, 2025	3,265 shares, last reported balance as of Feb 24, 2025
Martin Hughes	May 10, 2023	6,089 shares, last reported balance as of May 9, 2023
Wendell Knox	Jan 26, 2023	33,128 shares, last reported balance as of Jan 24, 2023
Mark Welzenbach	Jan 4, 2023	19,828 shares, last reported balance as of Dec 31, 2022
Harriett Taggart	May 11, 2022	14,577 shares, last reported balance as of May 10, 2022
Ann Tripp	Jan 5, 2022	17,645 shares, last reported balance as of Dec 31, 2021
Daniel Henry	May 13, 2021	15,356 shares, last reported balance as of May 11, 2021
Mark Berthiaume	Mar 30, 2021	10,824 shares, last reported balance as of Mar 26, 2021
Kevin Condron	Jan 25, 2021	28,021 shares, last reported balance as of Jan 4, 2021
Kendall Huber	Mar 30, 2020	36,234 shares, last reported balance as of Mar 27, 2020
Kathleen deCastro	Jul 1, 2019	3,577 shares, last reported balance as of Jun 28, 2019
Michael Price	May 16, 2019	3,462 shares, last reported balance as of May 14, 2019
John Fowle	Oct 26, 2018	2,898 shares, last reported balance as of Oct 25, 2018
Michael Angelini	Jan 29, 2018	94,418 shares, last reported balance as of Jan 2, 2018
Richard Booth	Jan 29, 2018	8,387 shares, last reported balance as of Jan 2, 2018
Mark Keim	Nov 30, 2017	No balance on record
Christine Bilotti-Peterson	Aug 28, 2017	1,760 shares, last reported balance as of Aug 25, 2017
Joseph Zubretsky	Feb 28, 2017	No balance on record
Johan Slabbert	Feb 10, 2017	7,437 shares, last reported balance as of Feb 9, 2017
Karen Francis	Jan 5, 2017	8,332 shares, last reported balance as of Jan 3, 2017
Frederick Eppinger	May 19, 2016	495,175 shares, last reported balance as of May 18, 2016
Eugene Bullis	May 17, 2016	825 shares, last reported balance as of May 13, 2016
Robert Stuchbery	May 12, 2016	6,754 shares, last reported balance as of May 10, 2016
Andrew Robinson	Mar 7, 2016	32,393 shares, last reported balance as of Feb 26, 2016
Neal Finnegan	May 21, 2015	33,452 shares, last reported balance as of May 19, 2015
David Greenfield	Mar 3, 2015	49,144 shares, last reported balance as of Mar 2, 2015
Robert Murray	Nov 12, 2014	25,220 shares, last reported balance as of Nov 7, 2014
Gregory Tranter	Nov 6, 2014	20,313 shares, last reported balance as of Nov 4, 2014
Mark Desrochers	Jun 16, 2014	10,188 shares, last reported balance as of Jun 13, 2014
David Gallitano	May 22, 2014	34,208 shares, last reported balance as of May 20, 2014
John Brennan	May 16, 2013	14,779 shares, last reported balance as of May 14, 2013
Marita Zuraitis	May 8, 2013	105,500 shares, last reported balance as of May 7, 2013
Maribeth Bearfield	Feb 28, 2013	3,800 shares, last reported balance as of Feb 26, 2013
Bryan Allen	Mar 7, 2012	24,065 shares, last reported balance as of Mar 6, 2012
Antonio dePadua	Mar 2, 2011	2,250 shares, last reported balance as of Feb 28, 2011
David Firstenberg	Sep 7, 2010	31,870 shares, last reported balance as of Sep 2, 2010
Steven Bensinger	Jan 8, 2010	5,500 shares, last reported balance as of Jan 6, 2010
Gail Harrison	Jan 5, 2010	17,240 shares, last reported balance as of Jan 4, 2010
Robert Myron	Jul 22, 2009	No balance on record
Gary Kusumi	Feb 25, 2009	2,750 shares, last reported balance as of Feb 23, 2009
James Hyatt	Feb 27, 2008	17,231 shares, last reported balance as of Feb 25, 2008
John Leahy	Aug 28, 2007	9,257 shares, last reported balance as of Aug 27, 2007
Edward Parry III	May 4, 2007	25,858 shares, last reported balance as of May 3, 2007
Herbert Varnum	May 18, 2006	15,570 shares, last reported balance as of May 16, 2006
John Kavanaugh	Feb 17, 2006	34,270 shares, last reported balance as of Feb 16, 2006
Susan Korthase	Oct 5, 2005	No balance on record
Bonnie Haase	Aug 26, 2005	1,059 shares, last reported balance as of Aug 25, 2005
Nancy Leaming	May 20, 2005	1,058 shares, last reported balance as of May 18, 2005
John Towers	May 4, 2005	4,265 shares, last reported balance as of May 2, 2005
Howard Jacobson	May 7, 2004	10,169 shares, last reported balance as of May 5, 2004
Michael Britt	Feb 11, 2004	3,682 shares, last reported balance as of Feb 6, 2004
Mhayse Samalya	Dec 11, 2003	3,239 shares, last reported balance as of Dec 10, 2003
Joseph Rovito	Nov 12, 2003	No balance on record
Mark McGivney	Nov 12, 2003	460 shares, last reported balance as of Nov 3, 2003
Bruce Anderson	Nov 4, 2003	No balance on record
Mark Hug	Oct 31, 2003	9,724 shares, last reported balance as of Oct 30, 2003
John Obrien		No balance on record

Spotted something wrong on this page? Report an error. We check every report against the SEC filing and list what we fix in the corrections log.

Hanover Insurance Group, Inc. insiders sold $16.2M in the past 12 months. How much of their stake is that?

What stands out

Who sold, and how much of their stake

Selling by month

Recent activity

Common questions

Is the Hanover Insurance Group, Inc. CEO selling stock?

Why are Hanover Insurance Group, Inc. insiders selling?

Are any Hanover Insurance Group, Inc. insiders buying?

The evidence

No plan disclosed · $11.7M

Taxes

Charitable gifts · 2.2K shares

Sales by month